Price Alert

Global Blood Therapeutics... (GBT)

NASDAQ: GBT · Real-Time Price · USD

68.49

0.01 (0.01%)

At close: Oct 04, 2022, 10:00 PM

Global Blood Therapeutics Revenue

Global Blood Therapeutics reported an annual revenue of $194.75M, reflecting a 57.31% growth. For the quarter ending June 30, 2022, Global Blood Therapeutics generated $71.55M in revenue.

Revenue (ttm)

194.75M

Revenue Growth

57.31%

Price / Sales Ratio

9.46

Revenue / Employee

426.15K

Employees

457

Market Cap

Revenue Chart

Revenue History

Fiscal Year End	Revenue	% Change
Dec 31, 2021	194.75M	+57.31%
Dec 31, 2020	123.8M	+5773.01%
Dec 31, 2019	2.11M	+Infinity%
Dec 31, 2018	0	n/a
Dec 31, 2017	0	n/a
Dec 31, 2016	0	n/a
Dec 31, 2015	0	n/a
Dec 31, 2014	0	n/a
Dec 31, 2013	0	n/a

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.